| Trial ID: | L5530 |
| Source ID: | NCT00968006
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Effect of Sitagliptin on Endothelial Progenitor Cells
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Change in circulating CD34+KDR+ endothelial progenitor cells, 4 weeks | Secondary: Change in SDF-1alpha concentrations, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Padova
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2009-10
|
| Completion Date: |
2010-01
|
| Results First Posted: |
|
| Last Update Posted: |
2010-04-05
|
| Locations: |
University of Padova, Medical School, Padova, 35100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00968006
|
